Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
Holding SNOA?
Track your performance easily

Sonoma Pharmaceuticals (SNOA) Financial Statements

267 Followers

Sonoma Pharmaceuticals Financial Overview

Sonoma Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-10.044; its P/E ratio is -0.42; Sonoma Pharmaceuticals is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.90. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 3.39M$ 3.44M$ 3.14M$ 2.73M$ 3.43M
Gross Profit$ 1.31M$ 1.09M$ 1.46M$ 990.00K$ 1.20M
EBIT$ -997.00K$ -1.36M$ -844.00K$ -1.30M$ -1.45M
EBITDA$ -958.00K$ -1.32M$ -799.00K$ -1.25M$ -1.41M
Net Income Common Stockholders$ -1.14M$ -1.07M$ -866.00K$ -1.48M$ -1.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.59M$ 3.13M$ 2.41M$ 2.14M$ 3.54M
Total Assets$ 13.67M$ 14.74M$ 14.62M$ 13.63M$ 15.89M
Total Debt$ 420.00K$ 608.00K$ 385.00K$ 522.00K$ 655.00K
Net Debt$ -2.17M$ -2.52M$ -2.02M$ -1.61M$ -2.89M
Total Liabilities$ 8.70M$ 8.60M$ 7.93M$ 7.96M$ 8.65M
Stockholders Equity$ 4.97M$ 6.14M$ 6.69M$ 5.67M$ 7.24M
Cash Flow-
Free Cash Flow$ -917.00K$ 155.00K$ -1.10M$ -1.23M$ -232.00K
Operating Cash Flow$ -912.00K$ 152.00K$ -1.10M$ -1.23M$ -215.00K
Investing Cash Flow$ -5.00K$ 18.00K$ -1.00K$ -2.00K$ -17.00K
Financing Cash Flow$ 636.00K$ 622.00K$ 1.32M$ -129.00K$ -135.00K
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

Sonoma Pharmaceuticals Debt to Assets

Sonoma Pharmaceuticals Cash Flow

Sonoma Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis